Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
azd9668 (1 trial)
saxagliptin (onglyza) (1 trial)
sitagliptin (januvia) (1 trial)
Diabetes Mellitus, Type 2 (Phase 2)
Insulin Resistance (Phase 2)
Trials (1 total)
Trial APIs (3 total)